Post-approval studies (Phase 4)Study completedNCT00632125What this trial is testingPost-authorization Safety Study in CKD Subjects Receiving HX575 i.v.Who this might be right forChronic Kidney Disease Sandoz 1,695
Large-scale testing (Phase 3)Study completedNCT06720233What this trial is testingEfficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal DialysisWho this might be right forAnemia Shenzhen Salubris Pharmaceuticals Co., Ltd. 37
Not applicableStudy completedNCT04487301What this trial is testingA Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney DiseaseWho this might be right forPeripheral Artery DiseaseEnd Stage Renal Disease on Dialysis Sanifit Therapeutics S. A. 36
Large-scale testing (Phase 3)Study completedNCT01195246What this trial is testingSafety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on HemodialysisWho this might be right forEnd Stage Renal Disease Dynavax Technologies Corporation 155
Not applicableUnknownNCT03005847What this trial is testingThe Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous IronWho this might be right forAnemiaChronic Kidney Disease Stage 5 Hadassah Medical Organization 20
Not applicableStudy completedNCT06022835What this trial is testingChlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal DialysisWho this might be right forPeritoneal Dialysis Catheter Exit Site InfectionEnd Stage Renal Disease on DialysisDialysis; Complications National Healthcare Group, Singapore 30
Large-scale testing (Phase 3)Looking for participantsNCT06933472What this trial is testingA Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaWho this might be right forHyperphosphatemiaChronic Kidney Disease, Receiving DialysisESRD (End-Stage Renal Disease)+1 more Alebund Pharmaceuticals 264
Not applicableStudy completedNCT05700851What this trial is testingImmuno-nutrition Supplementation in HaemodialysisWho this might be right forChronic Kidney Disease Requiring Chronic Dialysis University of Nottingham 17
Large-scale testing (Phase 3)Study completedNCT00413894What this trial is testingIntravenous Mircera for the Treatment of Anemia in Dialysis Patients.Who this might be right forAnemia Hoffmann-La Roche 424
Post-approval studies (Phase 4)Study completedNCT00379899What this trial is testingADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisWho this might be right forChronic Kidney DiseaseEnd Stage Renal DiseaseCoronary Artery Calcification+8 more Amgen 360
Not applicableStudy completedNCT01149291What this trial is testingFollow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismWho this might be right forSecondary HyperparathyroidismEnd Stage Renal Disease AbbVie (prior sponsor, Abbott) 511
Early research (Phase 1)Study completedNCT01872026What this trial is testingExamination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing HemodialysisWho this might be right forPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis TherapyPharmacodynamics of ASP7991Pharmacokinetics of ASP7991 Astellas Pharma Inc 14
Post-approval studies (Phase 4)Study completedNCT00369733What this trial is testingSTAAR-3 Clinical StudyWho this might be right forChronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more Amgen 443
Not applicableStudy completedNCT02154815What this trial is testingPre-emptive Kidney Transplantation Quality of LifeWho this might be right forRenal InsuffiencyKidney Transplantation Nantes University Hospital 390
Post-approval studies (Phase 4)Looking for participantsNCT06676696What this trial is testingStudy to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft FailureWho this might be right forRenal Failure , ChronicGraft FailureGraft Rejection+2 more Hospital Universitari Vall d'Hebron Research Institute 202
Not applicableStudy completedNCT04194164What this trial is testingDevelopment of Fluid Intake App for Management of Fluid Intake During Hemodialysis , Full Scale TrialWho this might be right forWeight Gain Wake Forest University Health Sciences 33
Early research (Phase 1)Study completedNCT01290029What this trial is testingStudy to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseWho this might be right forChronic Kidney DiseaseHyperparathyroidism, SecondarySecondary Hyperparathyroidism Amgen 14
Large-scale testing (Phase 3)Study completedNCT07030595What this trial is testingAP301 Efficacy and Safety in Chinese Dialysis Patients With HyperphosphatemiaWho this might be right forESRD (End Stage Renal Disease)Chronic Kidney Disease(CKD)Hyperphosphatemia+3 more Alebund Pharmaceuticals 474
Post-approval studies (Phase 4)Study completedNCT00737711What this trial is testingTwo-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.Who this might be right forAnemia Hoffmann-La Roche 189
Testing effectiveness (Phase 2)Study completedNCT00680043What this trial is testingSafety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESAWho this might be right forAnemiaChronic Renal FailureChronic Kidney Disease Affymax 114